These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
615 related articles for article (PubMed ID: 3001275)
41. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe. Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474 [TBL] [Abstract][Full Text] [Related]
42. Competitive antagonism at thromboxane receptors in human platelets. Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580 [TBL] [Abstract][Full Text] [Related]
43. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells. Matsuda K; Mathur RS; Duzic E; Halushka PV Am J Physiol; 1993 Dec; 265(6 Pt 1):E928-34. PubMed ID: 8279549 [TBL] [Abstract][Full Text] [Related]
44. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation. Vezza R; Nenci GG; Gresele P J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121 [TBL] [Abstract][Full Text] [Related]
45. Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes. Parent CA; Lagarde M; Venton DL; Le Breton GC J Biol Chem; 1992 Apr; 267(10):6541-7. PubMed ID: 1532390 [TBL] [Abstract][Full Text] [Related]
46. Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes. Theis JG; Dellweg H; Perzborn E; Gross R Biochem Pharmacol; 1992 Aug; 44(3):495-503. PubMed ID: 1387312 [TBL] [Abstract][Full Text] [Related]
48. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor. Gillard JW; Morton HE; Fortin R; Yoakim C; Girard Y; Lord A; Ethier D; Leveille C; Letts G; Evans J Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557 [No Abstract] [Full Text] [Related]
49. Purification and characterization of the human platelet TXA2/PGH2 receptor. Narumiya S; Ushikubi F; Nakajima M; Hirata M; Okuma M Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():339-46. PubMed ID: 1825566 [No Abstract] [Full Text] [Related]
50. A common binding site for primary prostanoids in vascular smooth muscles: a definitive discrimination of the binding for thromboxane A2/prostaglandin H2 receptor agonist from its antagonist. Hanasaki K; Arita H Biochim Biophys Acta; 1989 Sep; 1013(1):28-35. PubMed ID: 2528990 [TBL] [Abstract][Full Text] [Related]
51. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction. Parise LV; Venton DL; Le Breton GC J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669 [TBL] [Abstract][Full Text] [Related]
52. [Measurement of platelet thromboxane A2/prostaglandin H2 receptor in asthmatic patients]. Hada S; Hashizume M; Yoshioka F; Nishii S; Yasunaga K Arerugi; 1993 May; 42(5):609-16. PubMed ID: 8323459 [TBL] [Abstract][Full Text] [Related]
53. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction. Johnson GJ; Leis LA; Dunlop PC J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362 [TBL] [Abstract][Full Text] [Related]
54. Difluorothromboxane A2 and stereoisomers: stable derivatives of thromboxane A2 with differential effects on platelets and blood vessels. Morinelli TA; Okwu AK; Mais DE; Halushka PV; John V; Chen CK; Fried J Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5600-4. PubMed ID: 2748606 [TBL] [Abstract][Full Text] [Related]